Allocations
MIddle market private equity firm The Sterling Group has completed the acquisition of the Dexter Axle business from Tomkins Industries, a subsidiary of Pinafore Holdings.
The investment is Sterling’s fourth investment in its third fund, an USD820 million fund raised in 2010. Dexter is the second business Sterling has acquired from Tomkins in the last fourteen months.
Dexter is a leading designer and manufacturer of trailer axle, brake, and suspension assemblies and related replacement parts and components for use primarily in the industrial and utility trailer and RV markets in North America. "For over 50 years, Dexter has provided customers
First Investors Financial Services Group has completed its previously announced merger with an affiliate of private equity firm Aquiline Capital Partners.
The total consideration to be received by the former holders of First Investors securities will be approximately USD100 million. First Investors, which is now a wholly-owned subsidiary of a company controlled by Aquiline Capital Partners, has ceased trading of its common stock on the OTC Pink Sheets.
Former shareholders of First Investors will receive instructions shortly for surrendering their stock certificates to Wells Fargo Bank, National Association, who will act as paying agent with respect to the merger. Each
Mindbody, a provider of online business management software to the beauty, health and wellness industry, has completed a USD35m investment round led by Institutional Venture Partners (IVP).
The company’s existing investors, Catalyst Investors and Bessemer Venture Partners (BVP), also participated in the latest investment.
The capital raised will be used to accelerate Mindbody’s international expansion and ongoing product development. Mindbody currently serves over 21,000 health, wellness and beauty-based businesses in 80 countries worldwide.
Mindbody’s SaaS business management solution helps local businesses manage all aspects of their operations within a single system, from web scheduling and staff management, to
Private equity firm GTCR has acquired Premium Credit from MBNA Europe, a subsidiary of Bank of America.
Premium Credit is a provider of payment facilitation and financing services in the UK and Ireland.
GTCR is partnering with new chief executive Andrew Doman and existing management of Premium Credit to recapitalise the company and further invest in the company’s technology and services offerings going forward. Total asset value was approximately GBP900m (USD1,450m).
Founded in 1988, Premium Credit works in partnership with a diverse network of insurance brokers and carriers to enable businesses and individuals to pay insurance premiums in instalments rather
Euro Choice II, the private equity investment programme focusing on the European market, has sold its majority stake in SENIOcare, a long-term care group in Switzerland, to funds managed by private equity investment group Waterland.
Founded in 1983, SENIOcare has 26 nursing homes across Switzerland and over 1,000 residents cared for by over 1,000 full or part-time employees. In 2012, SENIOcare will achieve a turnover of about CHF100m.
Since the investment in late 2007, SENIOcare has seen substantial growth in sales and earnings through focused business development and a re-organisation of the company to tackle growth.
“Management and staff have
TowerBrook Capital Partners has acquired a majority interest in Vistage International, the world’s largest for-profit peer-advisory membership organisation of chief executives and business executives.
With more than 16,000 members in 15 countries, Vistage delivers leadership development and business value to CEOs and key executives in the US and around the world through a professionally-facilitated peer-advisory process, one-on-one coaching and mentoring, content from experts, and connectivity forums.
Vistage was founded in 1957 as TEC (The Executive Committee), a forum for business leaders to share their issues and experiences to help each other generate better decisions and results for their companies. Today,
European private equity firm Cinven has completed its acquisition of Amdipharm, the family-owned international niche pharmaceuticals business, for a total consideration of GBP367m.
This deal follows Cinven’s acquisition of Mercury Pharma, an international specialty pharmaceuticals company, in August 2012.
Amdipharm will be merged, over time, with Mercury Pharma. The combined group has an enterprise value in excess of GBP830m, with revenues approaching GBP250m and a portfolio of more than 200 drugs.
Cinven originated these investments through its healthcare sector focus. Its strategy is to grow a global niche pharmaceuticals business, both organically and through further acquisition opportunities, including
Ecorse Investments, a company indirectly owned by funds managed by private equity fund Advent International, has closed its tender offer for the sale of EKO Holding Group shares, reaching a total subscription level of 97.98 per cent.
According to the schedule provided in the tender offer document for the sale of EKO Holding shares, the subscription period closed on 29 October 2012.
Through the tender offer, the shareholders subscribed to sell the total number of 47,632,553 shares, which is equal to a 97.98 per cent stake in the company.
The sales of 62.14 per cent of the shares have already
Pentaho has raised USD23m in a C funding round led by New Enterprise Associates (NEA), with participation from additional existing investors Benchmark Capital, Index Ventures and DAG Ventures.
Pentaho will use the funds to expand its development, engineering, services, sales and marketing efforts needed to support its continued growth and leadership in big data analytics.
"Pentaho Business Analytics, with its tightly-coupled data integration, business analytics and big data capabilities in one easy-to-use and cost-effective platform, has become the go-to solution for companies embarking on big data programmes," says Quentin Gallivan (pictured), chairman and chief executive at Pentaho. "Pentaho has a
AXA Private Equity is providing EUR100m of additional financing to support the development of Ceva.
The deal follows AXA Private Equity’s first investment of EUR30m in 2007.
Ceva is an animal health company, which since becoming independent in 1999, has grown by more than 10 per cent per year, well above the industry average, thanks to an internal growth strategy focused on developing innovative products combined with external growth achieved through build-ups.
The management of Ceva became the majority shareholders in the group in 2007, following the third in a series of LBO’s supported by NiXEN, Euromezzanine and, in 2010,
Events
12 November, 2026 – 8:00 am
12 November, 2026 – 5:00 pm
